Möller G, van Grunsven E G, Wanders R J, Adamski J
GSF-National Research Center of Environment and Health, Institute of Experimental Genetics, Ingolstädter Landstrasse 1, 85764, Neuherberg, Germany.
Mol Cell Endocrinol. 2001 Jan 22;171(1-2):61-70. doi: 10.1016/s0303-7207(00)00388-9.
Peroxisomal disorders appear with a frequency of 1:5000 in newborns. They are caused either by peroxisomal assembly defects or by deficiencies of single peroxisomal enzymes. The phenotypes vary widely: affected humans may die very early in life within a few days to several months as a result of the impairment in essential peroxisomal functions as, for example, in Zellweger syndrome, or they may show only minor disabilities as is in acatalasemia. The deficiency of D-bifunctional protein, an enzyme involved in peroxisomal beta-oxidation of certain fatty acids and the synthesis of bile acids, causes a very severe, Zellweger-like phenotype. A number of different mutations in the gene coding for the enzyme were found in humans causing the total or partial loss of its enzymatic function. This paper gives a review of cases and their molecular basis.
过氧化物酶体疾病在新生儿中的出现频率为1:5000。它们是由过氧化物酶体组装缺陷或单一过氧化物酶体酶缺乏引起的。其表型差异很大:受影响的人可能由于基本过氧化物酶体功能受损,在生命早期几天至几个月内死亡,例如在泽尔韦格综合征中,或者可能仅表现出轻微残疾,如在无过氧化氢酶血症中。D-双功能蛋白缺乏,这种酶参与某些脂肪酸的过氧化物酶体β-氧化和胆汁酸的合成,会导致非常严重的、类似泽尔韦格综合征的表型。在编码该酶的基因中发现了许多不同的突变,这些突变导致了该酶功能的全部或部分丧失。本文对这些病例及其分子基础进行了综述。